Clinical Trial Update: Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of mycophenolate mofetil (CellCept) and sirolimus (Rapamune) in kidney transplant recipients; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rapamune (sirolimus)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-02-24